{
    "doi": "https://doi.org/10.1182/blood.V130.Suppl_1.5202.5202",
    "article_title": "Near-Infrared Fluorescence In-Vivo Imaging of Non-Hodgkin Lymphoma Using Cy7-Bevacizumab ",
    "article_date": "December 7, 2017",
    "session_type": "625. Lymphoma: Pre-Clinical\u2014Chemotherapy and Biologic Agents",
    "abstract_text": "Introduction: Tumor angiogenesis is necessary for tumor growth and metastasis. Of the many known inducers that promote tumor angiogenesis, vascular endothelial growth factor (VEGF) plays the most important role. Increased VEGF expression has been found in many tumor types, including non-Hodgkin lymphoma (NHL). Bevacizumab is a humanized monoclonal antibody that recognizes all known isoforms of VEGF. This study aims to design a diagnostic molecular probe, Cy7-Bevacizumab, in which Cy7 is a near-infrared fluorescent dye designed to in-vivo non-invasively identify VEGF expression in NHL tumors. Methodology: VEGF expression was confirmed using flow cytometry on NHL cell line Toledo. Cy7-Bevacizumab was synthesized through nucleophilic substitution reaction between monofunctional N-hydroxysuccinimide ester (Cy7-NHS) and Bevacizumab [1]. After purification, the conjugate was characterized by SDS-PAGE and spectrophotometry. For in-vivo imaging, Cy7-Bevacizumab (1 nmol) was injected intravenously in NHL tumor-bearing Balb/c nude mice ( n =3) and was evaluated with near-infrared fluorescence (NIRF) at 2, 6, 24, 48, 72 and 96 h post-injection. After 96 h the lymph nodes accumulation was analyzed by ex-vivo NIRF images. Results: Flow cytometry showed that NHL Toledo cell line expresses high levels of VEGF. Bevacizumab was successfully labeled with Cy7, as shown by SDS-PAGE and spectrophotometry. Non-invasively NIRF in-vivo imaging of NHL tumor-bearing Balb/c nude mice allowed identification of tumors up to 96 h post-injection. Ex-vivo NIRF images confirmed tracer deposition at tumors. Conclusions: NHL Toledo cell line expresses VEGF. Cy7 labeled Bevacizumab has the potential to become an optical imaging agent for VEGF expressing tumors such as NHL, being possibly useful in guiding surgical excision of tumors and biopsies, which merits further evaluation. Acknowledgments: Agencia Nacional de Innovaci\u00f3n e Investigaci\u00f3n - Uruguay (ANII), Roche Laboratories, Pro.In.Bio (Uruguay), PEDECIBA Qu\u00edmica (Uruguay)) and Comisi\u00f3n Sectorial de Investigaci\u00f3n Cient\u00edfica-Universidad de la Rep\u00fablica-Uruguay (CSIC, UdelaR) I+D Grupos Oncolog\u00eda Nuclear. Disclosures: No relevant conflicts of interest to declare. References: 1. Camacho, X; Machado, CL; Garc\u00eda, MF; Gambini, JP; Banchero, A; Fern\u00e1ndez, M; Oddone, N; Bertolini Zanata, D; Rosal, C; Buschpiguel, CA; Chammas, R; Riva, E; Cabral, P. \"Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non -Hodgkin Lymphoma\". Oncology, 15(92):229-42, 2017. Figure 1 View large Download slide Figure 1 View large Download slide  Close modal Disclosures No relevant conflicts of interest to declare.",
    "topics": [
        "bevacizumab",
        "diagnostic imaging",
        "fluorescence",
        "lymphoma, non-hodgkin",
        "vascular endothelial growth factor a",
        "neoplasms",
        "flow cytometry",
        "sodium dodecyl sulfate-polyacrylamide gel electrophoresis",
        "spectrophotometry",
        "tumor angiogenesis"
    ],
    "author_names": [
        "Ximena Camacho, MSc",
        "Carolina Perroni",
        "Mara de Souza Junqueira",
        "Marcelo Fernandez",
        "Silvina Bustos",
        "Carlos Buchpiguel",
        "Roger Chammas",
        "Juan Pablo Gambini",
        "Pablo Cabral",
        "Eloisa Riva, MD"
    ],
    "author_dict_list": [
        {
            "author_name": "Ximena Camacho, MSc",
            "author_affiliations": [
                "Centro de Investigaciones Nucleares, Facultad de Ciencias, Montevideo, Uruguay "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Carolina Perroni",
            "author_affiliations": [
                "Centro de Investigaciones Nucleares, Facultad de Ciencias, Montevideo, Uruguay "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mara de Souza Junqueira",
            "author_affiliations": [
                "Nuclear Medicine Medical Investigation Laboratory LIM43, Hospital das Cl\u00ednicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marcelo Fernandez",
            "author_affiliations": [
                "Centro de Investigaciones Nucleares, Facultad de Ciencias, Montevideo, Uruguay "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Silvina Bustos",
            "author_affiliations": [
                "Centro de Investiga\u00e7\u00e3o Translacional em Oncolog\u00eda, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carlos Buchpiguel",
            "author_affiliations": [
                "Nuclear Medicine Medical Investigation Laboratory LIM43, Hospital das Cl\u00ednicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Roger Chammas",
            "author_affiliations": [
                "Centro de Investiga\u00e7\u00e3o Translacional em Oncolog\u00eda, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Sao Paulo, Brazil "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Juan Pablo Gambini",
            "author_affiliations": [
                "Centro de Investigaciones Nucleares, Hospital de Cl\u00ednicas, Facultad de Medicina, Montevideo, Uruguay "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pablo Cabral",
            "author_affiliations": [
                "Centro de Investigaciones Nucleares, Facultad de Ciencias, Montevideo, Uruguay "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Eloisa Riva, MD",
            "author_affiliations": [
                "C\u00e1tedra de Hematolog\u00eda, Hospital de Cl\u00ednicas, Facultad de Medicina, Montevideo, Uruguay"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-11T12:58:34",
    "is_scraped": "1"
}